Department of Pharmacy, Peking University First Hospital, Beijing, People's Republic of China.
Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, People's Republic of China.
Pharmacoepidemiol Drug Saf. 2022 Feb;31(2):117-127. doi: 10.1002/pds.5385. Epub 2021 Nov 24.
Nonsteroidal anti-inflammatory drugs (NSAIDs) are regarded as nephrotoxins. Children commonly use NSAIDs and are susceptible to nephropathy, but the relationship between acute kidney injury (AKI) and use of NSAIDs is not well examined yet.
To evaluate the relationship between AKI and use of NSAIDs in hospitalized pediatric patients who are susceptible to nephropathy.
We conducted this systematic review and meta-analysis of observational studies by searching PubMed, Embase, and Cochrane Database for articles published up to June 1, 2020. Reports included involved children (age < 18 years) who used NSAIDs for various reasons and were admitted in the hospital. The main outcome measure was whether AKI occurred, and pooled odds ratio (OR) and 95% confidence intervals (CI) were calculated using generic inverse variance methods.
Seven studies reporting risk of AKI in the hospitalized pediatric patients receiving NSAIDs were included applying a random-effects model. In the hospitalized pediatric population, the pooled OR of AKI for present NSAID exposure was 1.55 (95%CI 1.26-1.92).
NSAID exposure was associated with an approximate 1.6-fold rise in the odds of developing AKI in hospitalized pediatric patients. Avoidance, cautious use of NSAIDs and further evidence are needed. This study was registered with PROSPERO (identifier: CRD42021219779).
非甾体抗炎药(NSAIDs)被认为是肾毒素。儿童通常使用 NSAIDs,并且容易发生肾病,但 NSAIDs 与急性肾损伤(AKI)之间的关系尚未得到充分研究。
评估易发生肾病的住院儿科患者中 AKI 与 NSAIDs 使用之间的关系。
我们通过搜索 PubMed、Embase 和 Cochrane 数据库,对截至 2020 年 6 月 1 日发表的观察性研究进行了系统评价和荟萃分析。报告包括因各种原因使用 NSAIDs 并住院的儿童(年龄 < 18 岁)。主要结局指标为是否发生 AKI,并使用通用逆方差法计算汇总优势比(OR)和 95%置信区间(CI)。
应用随机效应模型,纳入了 7 项报告 NSAIDs 暴露与住院儿科患者 AKI 风险的研究。在住院儿科人群中,目前 NSAID 暴露发生 AKI 的汇总 OR 为 1.55(95%CI 1.26-1.92)。
NSAIDs 暴露与住院儿科患者 AKI 发生的几率增加约 1.6 倍有关。需要避免、谨慎使用 NSAIDs,并进一步提供证据。本研究已在 PROSPERO(标识符:CRD42021219779)上注册。